Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,115.00    -15.00 (-0.21%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.54b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Trading Statement

17 Mar 2011 07:00

RNS Number : 0949D
Diploma PLC
17 March 2011
 



 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

17 March 2011

 

 

 

DIPLOMA PLC

 

TRADING UPDATE

 

 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing a trading update, ahead of going into close period at 31 March 2011.

 

Trading

The strong increase in both revenues and profitability reported in the first quarter has continued through the second quarter, boosted by strong contributions from acquired businesses. Group revenues in the six months ended 31 March 2011 are expected to be ca. 25% ahead of the comparable period in FY2010 and underlying revenues, after adjusting for currency effects and acquisitions, are likely to increase by ca. 16% against the comparable period last year.

 

The increase in revenues has been achieved while still maintaining tight control of operating costs and operating margins have further improved in each of the Group's three sectors. The combination of increasing revenue and margins will result in a significant increase in operating profit in the six months ending 31 March 2011, compared to the comparable period last year, part of which suffered from the impact of the economic downturn.

 

Subject to there being no significant changes in the major economies, the Directors expect continuing strength in revenues and operating margins across the Group's businesses and that the Group's adjusted profit before tax* for the year ending 30 September 2011 will be materially ahead of the current market consensus of £36.3m.

 

Acquisitions

As indicated in the IMS issued on 12 January 2011, pursuant to the Sale and Purchase Agreement dated 28 July 2007 for the acquisition of AMT Vantage Inc, the Group has now completed the acquisition of all of the outstanding shares from the minority shareholders for aggregate consideration of £12.3m (C$19.5m). Together with the acquisition of Carsen Medical Inc. in December 2010, the Group has invested a total of £27.5m during the half year in acquiring businesses.

 

Financial Position

The continuing strong trading activity, together with a return to the more normal seasonal historic trends in working capital, has contributed to a significant increase in working capital in the first half of the year. Following the payment of dividends to shareholders, including payments to minority shareholders, the Group expects to have net debt of ca. £5m at 31 March 2011. In the second half of the year, the Group expects to generate strong free cash flow, which subject to further acquisition expenditure, should result in the Group having net cash funds at 30 September 2011.

 

The Directors will provide a further update on trading prospects for the year on Tuesday, 17 May 2011, as part of their announcement of the Group's results for the six months year ending 31 March 2011.

 

 

 

*

 

Adjusted profit before tax is defined as profit before tax and before the costs of restructuring or rationalisation of operations, the profit or loss relating to the sale of property or businesses, fair value remeasurements under IAS 32 and IAS 39 in respect of future purchases of minority interests and acquisition related charges, as set out in the Group's FY2010 Annual Report.

 

 

 

Notes:

 

1. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

 

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

 

 

 

 

 

NOTE TO EDITORS:

 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

 

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

 

The Group employs ca. 875 employees and its principal operating businesses are located in the UK, Germany, US and Canada.

 

Over the last five years, the Group has grown adjusted earnings per share at an average of ca. 14% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £305m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUQAWUPGGQQ
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.